DrugPatentWatch Database Preview
Cumberland Pharms Company Profile
Email this page to a colleague
What is the competitive landscape for CUMBERLAND PHARMS, and what generic alternatives to CUMBERLAND PHARMS drugs are available?
CUMBERLAND PHARMS has seven approved drugs.
There are twenty-six US patents protecting CUMBERLAND PHARMS drugs.
There are one hundred and eighty-two patent family members on CUMBERLAND PHARMS drugs in thirty-eight countries and fifteen supplementary protection certificates in fourteen countries.
Summary for Cumberland Pharms
| International Patents: | 182 |
| US Patents: | 26 |
| Tradenames: | 8 |
| Ingredients: | 7 |
| NDAs: | 7 |
Drugs and US Patents for Cumberland Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharms | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-002 | Sep 11, 2009 | RX | Yes | Yes | 7,351,691 | ⤷ Sign up for a Free Trial | Y | Y | ⤷ Sign up for a Free Trial | ||
| Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | RX | Yes | Yes | 8,871,810 | ⤷ Sign up for a Free Trial | ⤷ Sign up for a Free Trial | ||||
| Cumberland Pharms | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | DISCN | Yes | No | 8,101,575 | ⤷ Sign up for a Free Trial | Y | ⤷ Sign up for a Free Trial | |||
| Cumberland Pharms | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | DISCN | Yes | No | 6,635,618 | ⤷ Sign up for a Free Trial | Y | Y | ⤷ Sign up for a Free Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cumberland Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | 6,727,286 | ⤷ Sign up for a Free Trial |
| Cumberland Pharms | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-002 | Sep 11, 2009 | 7,008,923 | ⤷ Sign up for a Free Trial |
| Cumberland Pharms | VIBATIV | telavancin hydrochloride | POWDER;INTRAVENOUS | 022110-001 | Sep 11, 2009 | 8,158,580 | ⤷ Sign up for a Free Trial |
| Cumberland Pharms | VAPRISOL | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-001 | Dec 29, 2005 | 5,723,606 | ⤷ Sign up for a Free Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CUMBERLAND PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 200 mg/mL, 30 mL vials | ➤ Subscribe | 2012-04-04 |
International Patents for Cumberland Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 100469788 | ⤷ Sign up for a Free Trial |
| Denmark | 2825039 | ⤷ Sign up for a Free Trial |
| Luxembourg | 91908 | ⤷ Sign up for a Free Trial |
| European Patent Office | 2453742 | ⤷ Sign up for a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cumberland Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1292612 | 36/2011 | Austria | ⤷ Sign up for a Free Trial | PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ HIEVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902 |
| 1292612 | 91908 | Luxembourg | ⤷ Sign up for a Free Trial | 91908, EXPIRES: 20260501 |
| 1292612 | 2011/037 | Ireland | ⤷ Sign up for a Free Trial | PRODUCT NAME: TELAVANCIN, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING TELAVANCIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902 |
| 1292612 | C 2012 002 | Romania | ⤷ Sign up for a Free Trial | PRODUCT NAME: TELAVANCIN SAU O SARE ACCEPTABILA FARMACEUTIC A ACESTUIAINCLUZAND CLORHIDRAT DE TELAVANCIN; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/705/001, RO EU/1/11/705/002; DATE OF NATIONAL AUTHORISATION: 20110902; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/11/705/001, EU/1/11/705/002; DATE OF FIRST AUTHORISATION IN EEA: 20110902 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
